Mylan eyes brand-name market
Mylan eyes brand-name market
Pittsburgh Tribune-Review - 1 hour ago
By Rick Stouffer, TRIBUNE-REVIEW Two years after Mylan Inc. completed a $6.8 billion deal for Merck KGaA's worldwide generic drug business, CEO Robert J. Coury is looking for deals to acquire ...